Shinhung (004080) Fundamentals 2026 — P/E 37.8x, Revenue Analysis | SniperIQ
Shinhung (004080) is a KR-listed Healthcare company in Medical - Devices with a market capitalization of ₩129.9B, trading at ₩14020.00 on the KSC. This SniperIQ fundamentals page covers Shinhung's valuation (P/E 37.8x, P/B 1.2x), profitability (net margin 3.2%), revenue (₩102.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shinhung's market cap?
Shinhung (004080) has a market capitalization of approximately ₩129.9B, trading at ₩14020.00 on the KSC. Market cap moves with the live share price.
What is Shinhung's P/E ratio?
Shinhung's trailing twelve-month P/E ratio is 37.8x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shinhung?
Shinhung runs a net profit margin of 3.2%, a gross margin of 30.7%, and an operating margin of 6.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shinhung generate?
Shinhung reported revenue of ₩102.6B for fiscal year 2025, with net income of ₩2.8B and earnings per share (EPS) of 311. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shinhung pay a dividend?
Shinhung offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shinhung financially healthy?
Shinhung carries a debt-to-equity ratio of 0.15x and a current ratio of 1.79x, with a market beta of 0.05. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shinhung a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shinhung (004080) the key facts are: market cap ₩129.9B, P/E 37.8x, revenue ₩102.6B, 52-week range 13150-14760. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shinhung's full fundamentals live
Get Shinhung's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.